Step Pharma

Step Pharma is advancing its lead CTP synthase 1 inhibitor candidate into the clinic this year in the hopes of treating an aggressive lymphoma indication with poor prognosis and limited second-line t

Morningside Ventures launched Adiso Therapeutics on 10 March with more than $60m invested to date in the Concord, MA-based start-up focusing on the underlying biology of inflammatory diseases without

Step Pharma has taken a big stride towards getting its first-in-class CTPS1 inhibitor into the clinic after closing a €35m series B financing. The French biotech, which raised €14.5m with its series

Biomedical innovation in Europe is still very strong and especially in the continent's universities from where starts-ups need to have time to develop before tackling commercialisation. That is the vi